Age differences in the sensitivity to clomipramine in an animal model of obsessive-compulsive disorder A. Fernández-GuastiR. E. UlloaH. Nicolini Original Investigation 13 February 2003 Pages: 195 - 201
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice William E. FantegrossiTomek GodlewskiJames H. Woods Original Investigation Pages: 202 - 211
Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus) N. G. MuggletonA. P. BowditchP. C. Pearce Original Investigation 13 February 2003 Pages: 212 - 220
Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers Ashwin A. PatkarRaman GopalakrishnanFrank T. Leone Original Investigation 13 February 2003 Pages: 221 - 227
Cognitive and motor function after administration of hydrocodone bitartrate plus ibuprofen, ibuprofen alone, or placebo in healthy subjects with exercise-induced muscle damage: a randomized, repeated-dose, placebo-controlled study George J. AllenTamara L. HartlCarl M. Maresh Original Investigation 28 January 2003 Pages: 228 - 233
Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study Yuan-Hwa ChouChrister HalldinLars Farde Original Investigation Pages: 234 - 240
Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice Yossef ItzhakSyed F. AliKaren L. Anderson Original Investigation 18 February 2003 Pages: 241 - 248
The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats B. J. GehrkeS. B. HarrodM. T. Bardo Original Investigation 13 February 2003 Pages: 249 - 257
Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-d-aspartate receptor antagonist MK-801 in mice Oscar P. Dall'IgnaAdriana L. da SilvaDiogo R. Lara Original Investigation 13 February 2003 Pages: 258 - 263
Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma Nora D. VolkowGene-Jack WangJames M. Swanson Original Investigation 13 February 2003 Pages: 264 - 270
Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine Cornelius SchüleThomas BaghaiRainer Rupprecht Original Investigation 28 January 2003 Pages: 271 - 275
Buspirone-induced antinociception is mediated by l-type calcium channels and calcium/caffeine-sensitive pools in mice Jian-Hui LiangXu-Hua WangJi-Wang Zheng Original Investigation 28 January 2003 Pages: 276 - 283
EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans R. H. McAllister-WilliamsA. E. Massey Original Investigation 13 February 2003 Pages: 284 - 293
Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI) Peter EichhammerBerthold LangguthGöran Hajak Original Investigation 01 February 2003 Pages: 294 - 297
Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys Donna M. PlattJoshua S. RodeferRoger D. Spealman Original Investigation 13 February 2003 Pages: 298 - 305
The motivational valence of nicotine in the rat ventral tegmental area is switched from rewarding to aversive following blockade of the α7-subunit-containing nicotinic acetylcholine receptor Steven R. LavioletteDerek van der Kooy Original Investigation 05 February 2003 Pages: 306 - 313